PHARMAC seeking feedback on funding Trikafta

4 December 2022 - PHARMAC has reached a provisional agreement with medicine supplier Vertex to fund Trikafta. ...

Read more →

‘Good news’ for Kiwi women as PHARMAC funds Utrogestan from today

1 December 2022 - The end of a decade long wait. ...

Read more →

New Zealand Pharmaceutical Schedule - 1 December 2022

1 December 2022 - The December 2022 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...

Read more →

The Government may have taken money from the DHB hospital budget to increase PHARMAC's funding

30 November 2022 -  In this year’s budget, the Government said it has increased PHARMAC's funding by 43% over the ...

Read more →

The cruellest tax: clipping the ticket on unfunded cancer drugs

28 November 2022 - Jo McKenzie-McLean’s life was turned upside down after a stage 4 bowel cancer diagnosis. ...

Read more →

GPs can't prescribe ADHD medication, some say that's a problem

24 November 2022 - When Ben Mitchell was first diagnosed with attention deficit hyperactivity disorder (ADHD), he waited four months to ...

Read more →

Kiwi myeloma cancer sufferers don’t have access to daratumumab, a drug available in Australia

21 November 2022 - Kiwi cancer sufferers are being denied a drug that saves lives in other countries, including Australia ...

Read more →

'Heartbreaking': parents of sick 11 month old want greater meningitis awareness

19 November 2022 - A cough quickly turned into a “horrible” few weeks for an Auckland family whose infant son ...

Read more →

PHARMAC welcomes Myeloma NZ as first patient advocacy group to present to PTAC

21 November 2022 - Myeloma New Zealand presented directly to PHARMAC’s Pharmacology and Therapeutics Advisory Committee (PTAC) on Thursday, making ...

Read more →

PHARMAC calls for applications for medicines for rare disorders

21 November 2022 - PHARMAC is calling for applications for medicines for rare disorders.  ...

Read more →

Diabetic accuses PHARMAC of faulty analysis of glucose monitors

17 November 2022 - Insulin-dependent diabetics say PHARMAC's decision to delay funding a potentially life-saving device appears to be based ...

Read more →

Expansion of access to MenB vaccine urgently needed

15 November 2022 - Meningococcal B is a rare but very serious disease, causing death and serious long-term disabilities. Even when ...

Read more →

Decision to fund long-acting paliperidone for people with schizophrenia and ibrutinib for people with chronic lymphocytic leukaemia

10 November 2022 - PHARMAC is pleased to announce a decision to fund two new medicines. ...

Read more →

Decision to fund vedolizumab for inflammatory bowel disease and brentuximab for rare lymphomas

10 November 2022 - PHARMAC is pleased to announce a decision to fund two new treatments: vedolizumab for inflammatory bowel ...

Read more →

PHARMAC widens access to pneumococcal vaccine

7 November 2022 - PHARMAC has announced today that all young tamariki will receive access to the PCV13 pneumococcal vaccine (Prevenar ...

Read more →